- Eli Lilly and Company
Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
Indianapolis, November 13 (ots/PRNewswire) -
- 13.11.2009, 15:11:41
- /
- OTE0006
- Eli Lilly and Company
World Heart Federation, Daiichi Sankyo and Lilly Partner to Improve Cardiovascular Health
Orlando, Florida (ots/PRNewswire) -
- 31.03.2009, 06:07:36
- /
- OTE0002
- Eli Lilly and Company
Cialis(R) (tadalafil) for Once-a-Day Use Approved for the Treatment of Erectile Dysfunction by European Commission
Indianapolis (ots/PRNewswire) -
- 25.06.2007, 13:42:13
- /
- OTE0003
- Eli Lilly and Company
Study Supports Activity of GEMZAR(R) (Gemcitabine HC1 for Injection) in the Treatment of Early-Stage Breast Cancer
Chicago (ots/PRNewswire) -
- 02.06.2007, 21:05:05
- /
- OTE0003
- Eli Lilly and Company
Investigational Targeted Therapy May Offer Progress For Non-Hodgkin's Lymphoma Patients
Indianapolis (ots/PRNewswire) - Data presented today offer evidence that an investigational targeted therapy may be useful in treating patients with the most common form of non-Hodgkin's lymphoma (NHL).
- 10.12.2005, 15:18:41
- /
- OTE0001
Alle Aussendungen
Alle Anhänge
